Highlights Numinus Wellness Inc.

Equities

NUMI

CA67054W1032

Delayed Toronto S.E. Other stock markets 09:30:00 2024-05-15 EDT			5-day change	1st Jan Change
0.08 ^CAD	+6.67%		-6.25%	-31.82%

05-07	Numinus Wellness to Focus on U.S. Operations as it Transitions Out of Canada	MT
05-07	Numinus Wellness Brief: Announces a strategic plan designed to streamline expenses and "Sharpen" focus on Higher-growth U.S. operations	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Numinus Wellness to Focus on U.S. Operations as it Transitions Out of Canada	05-07	MT
Numinus Wellness Brief: Announces a strategic plan designed to streamline expenses and "Sharpen" focus on Higher-growth U.S. operations	05-07	MT
Cybin Selects Numinus Wellness Inc.'s Cedar Clinical Research as clinical research site for Its Phase 3 Study of CYB003	04-17	CI
Numinus Wellness Drops 25% as it Explores Options for its Canadian Operations; FQ2 Profit Falls	04-15	MT
Toronto Stocks Edge Lower; Parkland Shares Up After Rebuffing Call for Strategic Review	04-15	DJ
Numinus Wellness Exploring Options For Canadian Operations; Comes After It Posted QoQ Decrease in Q2 Revenue, Gross Profit	04-15	MT
Numinus Wellness Brief: Co Has decided to Explore Opportunities to "Redefine, divest and/or discontinue" its Canadian clinical operations	04-15	MT
Numinus Wellness Brief: Says To Focus on U.S. operations and Citing "Strategic Adjustments" in its Canadian Market Presence	04-15	MT
Numinus Wellness Posts QoQ Decrease in Q2 Revenue, Gross Profit	04-15	MT
An undisclosed buyer agreed to acquire Canadian clinical operations from Numinus Wellness Inc..	04-14	CI
Numinus Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	04-12	CI
Numinus Wellness Submits Clinical Trial Application to Health Canada	03-20	MT
Numinus Wellness Inc. Submits Clinical Trial Application	03-20	CI
Numinus Wellness Corrects Its Own Statement Related To Holdings In Co-Investment Feeder Fund 3; Announced $6 Million Bought Deal Public Offering	02-01	MT
Numinus Wellness Agrees to Sell Holdings in Alto Neuroscience	02-01	MT
Numinus Wellness Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	01-15	CI
Numinus Wellness Brief: Says Has initiated a review process to "Explore, review and evaluate a broad range of strategic alternatives" that may be available to it to unlock shareholder value	01-15	MT
Numinus Wellness Brief: Q1 FY24 Revs of $5.9 million, a 3.0% decline over Q4 2023; Loss and Comprehensive Loss $4,351,472	01-15	MT
Cedar Clinical Research Selected as Clinical Research Site for Beckley Psytech's Phase 2B Study	12-15	CI
Numinus on MAPS Application to the FDA for MDMA-Assisted Therapy for PTSD	12-13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Numinus Wellness Inc.

Equities

NUMI

CA67054W1032

Highlights

Filters